MAPT and Alzheimer disease: Plasma biomarker profiling recapitulated hallmark AD processes including β-amyloid deposition, tau hyperphosphorylation, oxidative stress, neuroinflammatory activation, and neurodegeneration while revealing metabolite–biomarker correlations that advance mechanistic understanding of AD pathogenesis.